Table 1 Definitions of the PQI according to the diagnostic code-based approach, the clinical measurement-based approach, and the reference method
From: Methods to identify the target population: implications for prescribing quality indicators
| Â | Diagnostic code-based | Clinical measurement-based | Reference (hybrid) method |
|---|---|---|---|
PQI-1 | Denominator: T2DM patients with diagnostic codes for hypertension | Denominator: T2DM patients with SBP≥140 mmHg | Denominator: T2DM patients with diagnostic codes for of hypertension OR SBP≥140 mmHg |
| Â | Numerator: Denominator AND prescription of any antihypertensive medication | Numerator: Denominator AND prescription of any antihypertensive medication | Numerator: Denominator AND prescription of any antihypertensive medication |
PQI-2 | Denominator: T2DM patients with diagnostic codes for hypertension and history of IHD or MI | Denominator: T2DM patients with SBP≥140 mmHg AND history of IHD or MI | Denominator: T2DM patients with diagnostic codes for hypertension OR SBP≥140 mmHg AND history of IHD or MI |
| Â | Numerator: denominator AND prescription of beta blocker | Numerator: Denominator AND prescription of beta blocker | Numerator: Denominator AND prescription of beta blocker |
PQI-3 | Denominator: T2DM patients with diagnostic codes for overweight OR obesity | Denominator: T2DM patients with BMI ≥25 | Denominator: T2DM patients with diagnostic codes for overweight OR obesity OR BMI≥25 |
| Â | Numerator: Denominator AND prescription of metformin | Numerator: denominator AND prescription of metformin | Numerator: denominator AND prescription of metformin |